Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,756 GBX | -1.07% | -2.98% | +21.09% |
04:26pm | GSK Says Depemokimab Reduced Asthma Attacks in 2 Late-Stage Studies | MT |
02:03pm | GSK's Potential Blockbuster Asthma Drug Shows Promise in Latest Trial -- 2nd Update | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.09% | 91.96B | |
+37.89% | 705B | |
+32.82% | 583B | |
-3.63% | 364B | |
+20.19% | 332B | |
+5.08% | 291B | |
+16.64% | 238B | |
-4.13% | 210B | |
+10.63% | 209B | |
+8.68% | 169B |
- Stock Market
- Equities
- GSK Stock
- News GSK plc
- GSK, Scynexis Sign License Deal for Fungal Infection Treatment